Hideki Tani

5.4k total citations
95 papers, 3.0k citations indexed

About

Hideki Tani is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Hideki Tani has authored 95 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 22 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Hideki Tani's work include Viral Infections and Vectors (27 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Viral Infections and Outbreaks Research (22 papers). Hideki Tani is often cited by papers focused on Viral Infections and Vectors (27 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Viral Infections and Outbreaks Research (22 papers). Hideki Tani collaborates with scholars based in Japan, United States and Australia. Hideki Tani's co-authors include Yoshiharu Matsuura, Tatsuo Miyamura, Shuetsu Fukushi, Kohji Moriishi, Masayuki Saijo, Masayuki Shimojima, Shigeru Morikawa, Hideki Aizaki, Satoshi Taniguchi and Koji Ishii and has published in prestigious journals such as The Journal of Cell Biology, PLoS ONE and Journal of Virology.

In The Last Decade

Hideki Tani

92 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Tani Japan 31 1.3k 1.1k 621 485 423 95 3.0k
Sven‐Erik Behrens Germany 31 556 0.4× 1.5k 1.3× 699 1.1× 787 1.6× 136 0.3× 62 3.1k
Hans Nitschko Germany 24 688 0.5× 445 0.4× 612 1.0× 304 0.6× 267 0.6× 52 1.9k
Encarnación Martı́nez-Salas Spain 44 699 0.5× 3.2k 2.8× 325 0.5× 271 0.6× 621 1.5× 119 5.0k
Denise Egger Switzerland 33 1.5k 1.1× 1.7k 1.5× 1.2k 1.9× 1.2k 2.4× 361 0.9× 57 4.6k
William M. Schneider United States 20 1.4k 1.0× 1.6k 1.4× 943 1.5× 332 0.7× 334 0.8× 33 4.4k
Tim Skern Austria 33 1.1k 0.8× 2.2k 2.0× 712 1.1× 79 0.2× 325 0.8× 102 4.1k
Kurt Bienz Switzerland 34 1.5k 1.2× 1.8k 1.6× 1.3k 2.1× 1.2k 2.4× 394 0.9× 70 4.8k
Hélène Dutartre France 26 716 0.5× 669 0.6× 270 0.4× 155 0.3× 131 0.3× 54 2.3k
Hengli Tang United States 34 1.0k 0.8× 1.8k 1.6× 1.1k 1.7× 926 1.9× 195 0.5× 66 3.9k
Hirofumi Akari Japan 34 1.2k 0.9× 693 0.6× 824 1.3× 155 0.3× 220 0.5× 140 3.2k

Countries citing papers authored by Hideki Tani

Since Specialization
Citations

This map shows the geographic impact of Hideki Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Tani more than expected).

Fields of papers citing papers by Hideki Tani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Tani. The network helps show where Hideki Tani may publish in the future.

Co-authorship network of co-authors of Hideki Tani

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Tani. A scholar is included among the top collaborators of Hideki Tani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Tani. Hideki Tani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2024). Low pre-infection levels of neutralizing antibody in breakthrough infections after bivalent BA.4–5 vaccine and practical application of dried blood spots. Vaccine. 42(22). 126029–126029.
3.
Sano, Kaori, et al.. (2024). Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc. Archives of Virology. 169(3). 40–40. 2 indexed citations
4.
Sakai, Shota, Yoshimi Shimizu, Takuma Kishimoto, et al.. (2024). Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne. Biological and Pharmaceutical Bulletin. 47(5). 930–940. 1 indexed citations
5.
Yoshida, Toshikazu, et al.. (2023). Long-Term Detection and Isolation of Severe Fever with Thrombocytopenia Syndrome (SFTS) Virus in Dog Urine. Viruses. 15(11). 2228–2228. 2 indexed citations
6.
Kawasuji, Hitoshi, Yoshitomo Morinaga, Hideki Tani, et al.. (2023). Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5. Microbiology Spectrum. 11(2). e0513122–e0513122. 12 indexed citations
7.
Maeda, T, et al.. (2023). Lactoferrin as a Possible Preventive and Therapeutic Agent Against SARS-CoV-2 Infection. Journal of Disaster Research. 18(1). 27–33. 1 indexed citations
8.
9.
Kimura, Miyuki, Satoshi Taniguchi, Junki Maruyama, et al.. (2023). Inhibitors of cannabinoid receptor 1 suppress the cellular entry of Lujo virus. Virology. 587. 109867–109867. 2 indexed citations
10.
Nagaoka, Kentaro, Hitoshi Kawasuji, Makito Kaneda, et al.. (2023). Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants. Viruses. 15(6). 1304–1304. 1 indexed citations
11.
12.
13.
Maeda, T, Miyuki Kimura, Hiroshi Ito, et al.. (2022). Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro. Biochemistry and Cell Biology. 100(4). 338–348. 6 indexed citations
14.
Taniguchi, Satoshi, Takuya Inagaki, Shigeru Tajima, et al.. (2022). Reverse Genetics System for Heartland Bandavirus: NSs Protein Contributes to Heartland Bandavirus Virulence. Journal of Virology. 96(7). e0004922–e0004922. 10 indexed citations
15.
Shimojima, Masayuki, Kunihiko Umekita, Taishi Onodera, et al.. (2022). Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model. Viruses. 14(8). 1665–1665. 10 indexed citations
16.
Yamada, Hiroshi, Satoshi Taniguchi, Masayuki Shimojima, et al.. (2021). M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 13(6). 1061–1061. 5 indexed citations
17.
Tani, Hideki, Miyuki Kimura, Long Tan, et al.. (2021). Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virology Journal. 18(1). 16–16. 37 indexed citations
18.
Kimura, Miyuki, Tatsuhiko Ozawa, Hiroyuki Kishi, et al.. (2020). Characterization of pseudotyped vesicular stomatitis virus bearing the heartland virus envelope glycoprotein. Virology. 556. 124–132. 11 indexed citations
19.
20.
Tani, Hideki, Takashi Komeno, Aiko Fukuma, et al.. (2018). Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS ONE. 13(10). e0206416–e0206416. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven‐Erik Behrens Breakdown of academic impact, for papers by Hans Nitschko Breakdown of academic impact, for papers by Encarnación Martı́nez-Salas Breakdown of academic impact, for papers by Denise Egger Breakdown of academic impact, for papers by William M. Schneider Breakdown of academic impact, for papers by Tim Skern Breakdown of academic impact, for papers by Kurt Bienz Breakdown of academic impact, for papers by Hélène Dutartre Breakdown of academic impact, for papers by Hengli Tang Breakdown of academic impact, for papers by Hirofumi Akari
Rankless by CCL
2026